Kang Zhang

Kang Zhang, MD, PhD is the professor of the Faculty of Medicine at the Macau University of Science and Technology. Dr. Zhang obtained his M.D. with Magna Cum Laude honors from Harvard Medical School and MIT joint MD program and his PhD in genetics from Harvard University. He did his postdoctoral training also at Harvard. He completed his residency in ophthalmology at Johns Hopkins University and his retina surgery fellowship at University of Utah. Among his honors include AAAS fellow, AIMBE fellow, memberships in Association of American Physicians and American Society of Clinical Investigation, Burroughs Wellcome Clinical Scientist Award in Translational Research; Outstanding Achievement Award of Chinese Ophthalmological Society, Lew R. Wasserman Merit Award and Senior Investigator Award from Research to Prevent Blindness; Charles Schepens Award for Excellence in Retina Research; and Johns Hopkins Medical Institutions Clinician Scientist Award, the Ophthalmologist. He was a faculty member at John Hopkins University, Cleveland Clinic Foundation, University of Utah, and University of California San Diego (UCSD). Dr. Zhang has published over 200 peer-reviewed manuscripts in top peer-reviewed journals covering a wide range of topics in genetics, epigenetics, stem cells, nanoengineering and 3D printing, clinical trials, and artificial intelligence. His cutting-edge research has been extensively covered by prominent news media including New York Times, Wall Street Journal, CBS 60 Minutes, The Guardian, LA Times, Xinhua News Agency, NBC, CBS, ABC, BBC, and CCTV.

Lab Information

Kang Zhang Laboratory, Macau University of Science and Technology

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Artificial Intelligence 0 Ophthalmology 0 Cancer Biology 0 Aging 0 Genetics 0

More

  • Post
  • Publication
  • Plasmid
  • Following (0)
  • Follower (1)


This guy hasn’t posted anything yet.

Hot Posts for You

Neutralizing antibodies (NAbs) are critical human immune defense mechanisms against viral infections. NAbs can bind to sites on the virus and inhibit entry of that virus into the host. It is a key parameter to evaluate COVID-19 vaccine efficacy per Guidelines from Development and ...Learn More


This 3D animation shows you how DNA is copied in a cell. It shows how both strands of the DNA helix are unzipped and copied to produce two identical DNA molecules. TranscriptDNA is a molecule made up of two strands twisted around each other in a double helix shape. Each strand is ...Learn More


IntroductionA gleam of light finally shone down on the global crisis of the prolonged battle against COVID-19, giving people hopes of preventive care and treatment in the near future by monoclonal antibodies against SARS-CoV-2. As stated the news of NIH’s phase III clinical ...Learn More


"Those who do not know history are obliged to repeat it" This famous phrase that could be from any history teacher to his suspended students has been attributed to great figures in history such as Napoleon or the philosopher George Santayana. In a modern version of it we could say ...Learn More


In recent years there is an increasing number of cytotoxic chemotherapeutic compounds with the ability to rapidly kill dividing cancer cells in preference to non-dividing healthy cells. Nevertheless, the major drawback of chemotherapy is that, in addition to damaging the cancer ...Learn More


The coronavirus pandemic caught everyone unprepared. We had to deal with the fear of an unknown virus which can be lethal for some people. And the whole world just stopped in an attempt to prevent the virus spread.Suddenly we had to adapt to a new way of living, socially isolated ...Learn More


This is the first episode of MolecularCloud Pioneer Scientist interview series. In this interview, MolecularCloud talks with Prof. Shuo Huang from Nanjing University about the recent publications of Dr. Huang’s team and the future prospect of biological nanopore technology. The ...Learn More


The increasing number of confirmed COVID-19 cases is prompting an unprecedented global effort to find a treatment for the disease. Given the fact that a new drug development could be a decade work from initial discovery to the marketplace, scientists are racing to search a cure ...Learn More


The previous article on precision medicine was focused on Pharmacogenomics as a fundamental aspect of cancer therapeutics. In this sequel, emphasis would be on the role of immuno-oncology in personalization of cancer therapy, citing anti PD therapy as an example with hypothetical ...Learn More


  1. Zhang, K., Liu, X., Shen, J., Li, Z., Sang, Y., Wu, X., ... & Ye, L. (2020). Clinically applicable AI system for accurate diagnosis, quantitative measurements, and prognosis of covid-19 pneumonia using computed tomography. Cell.

  2. Xu, X., Sun, J., Nie, S., Li, H., Kong, Y., Liang, M., ... & Peng, J. (2020). Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nature Medicine, 1-3.

  3. Liang, H., Tsui, B. Y., Ni, H., Valentim, C. C., Baxter, S. L., Liu, G., ... & He, L. (2019). Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence. Nature medicine, 25(3), 433-438.

  4. Moreno, A. M., Fu, X., Zhu, J., Katrekar, D., Shih, Y. R. V., Marlett, J., ... & Varghese, S. (2018). In situ gene therapy via AAV-CRISPR-Cas9-mediated targeted gene regulation. Molecular Therapy, 26(7), 1818-1827.

  5. Kermany, D. S., Goldbaum, M., Cai, W., Valentim, C. C., Liang, H., Baxter, S. L., ... & Dong, J. (2018). Identifying medical diagnoses and treatable diseases by image-based deep learning. Cell, 172(5), 1122-1131.


This guy hasn’t plasmids anything yet.

Hot plasmids


This guy has no following anyone.

Popular Cloud Scientists

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2025 MolecularCloud